Metro Pain
Metro Pain Group is an Australian multidisciplinary interventional pain management practice operating clinics in Melbourne and Brisbane, delivering specialist consultations, image-guided procedures, and neuromodulation for chronic and complex pain patients referred by GPs and allied health professionals.
- Company typePrivate
- Founded1985
- HeadquartersClayton, Australia
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Metro Pain does
Metro Pain Group (formerly Metropolitan Spinal Clinic) is a privately held, founder-led specialist medical practice founded in 1985 in Melbourne, Australia. The company provides multidisciplinary interventional pain management for chronic and complex pain conditions including back pain, sciatica, arthritis, nerve pain, fibromyalgia, pelvic pain, and headaches. Services are delivered across two clinic locations — Monash House Private Hospital in Clayton, Victoria, and Bowen Hills Medical Specialist Centre in Brisbane, Queensland — through a team of specialist pain physicians, anaesthetists, rehabilitation physicians, sports medicine doctors, and physician associates/physiotherapists under Clinical Director Dr Paul Verrills and Managing Director Dr Dan Bates.
The practice's core offering is image-guided interventional pain medicine, combining diagnostic and therapeutic injection procedures (medial branch blocks, facet joint injections, epidural injections, sacroiliac joint injections, stellate ganglion blocks), radiofrequency neurotomy, regenerative therapies (PRP), and implanted neuromodulation devices (spinal cord and peripheral nerve stimulators) with medication management, ketamine infusions, and rehabilitation. The underlying technology is a multidisciplinary treatment framework anchored on a "Halving Pain" clinical philosophy targeting 50% or greater pain reduction, supported by the affiliated Metro Pain Research Institute which runs clinical trials in pain medicine, biologics, and neuromodulation.
Metro Pain monetises through professional service fees: consultations priced at A$400 standard / A$250 pensioner for initial visits and A$175–$250 for reviews, plus separate procedure invoices billed by the doctor, anaesthetist, and hospital (known GAP of ~A$500 per side for insured patients). Revenue is diversified across self-pay, private health insurance, WorkCover, TAC, and DVA claims. Patient acquisition is sales-led via referrals from GPs, physiotherapists, chiropractors, and psychologists, supported by an informational website and online referral form. The practice has treated more than 84,000 patients cumulatively since 1985 and operates with no disclosed external investment, parent company, or public listing.
Metro Pain firmographics
Firmographics- Name
- Metro Pain
- Legal name
- Metro Pain Group
- Website
- https://metropain.com.au
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Metro Pain Group is an Australian multidisciplinary interventional pain management practice operating clinics in Melbourne and Brisbane, delivering specialist consultations, image-guided procedures, and neuromodulation for chronic and complex pain patients referred by GPs and allied health professionals.
- Ownership category
- akta.pro rank
Metro Pain industry classification
Industry- Product category
- Pain Management Healthcare Services
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Pain Management Clinics (Interventional & Medical) (HLAFABAH)
- akta.pro secondary industries
- Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM), Pain Management & Interventional Procedure Centers (HLAFAIAH), Pain Management (Spine & Musculoskeletal) (HLAKALAM)
Keywords
Where Metro Pain is headquartered
LocationHeadquarters
- HQ city
- Clayton
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Metro Pain business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Consultation Services: Revenue from initial consultations ($400 standard, $250 pensioner) and review consultations (short $175, long $250 standard).
- Pain Procedure Services: Revenue from interventional pain procedures including cortisone injections, nerve blocks, radiofrequency ablation, and surgical assessments. Procedures generate separate invoices from doctor, anaesthetist, and hospital fees.
- Government and Insurance Claims: Accepts WorkCover, TAC, and DVA claims, providing additional revenue pathways for eligible patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Initial Consultation - Standard Rate |
| Unit Pricing | Pay-as-you-go | Initial Consultation - Pensioner Rate |
| Unit Pricing | Pay-as-you-go | Review Consultation Short (15 min) - Standard |
| Unit Pricing | Pay-as-you-go | Review Consultation Short (15 min) - Pensioner |
| Unit Pricing | Pay-as-you-go | Review Consultation Long (30 min) - Standard |
| Unit Pricing | Pay-as-you-go | Review Consultation Long (30 min) - Pensioner |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Metro Pain product offering
Product offeringCore offering
Metro Pain is a specialist interventional pain management clinic that diagnoses and treats chronic and complex pain conditions through personalised, evidence-based treatment plans. It combines specialist consultations, image-guided injection procedures (cortisone, nerve blocks, radiofrequency neurotomy), neuromodulation devices (spinal cord and peripheral nerve stimulators), regenerative medicine (PRP), ketamine infusions, and multidisciplinary rehabilitation. Services are delivered in-person at two Australian clinic locations (Melbourne and Brisbane) under a "Halving Pain" treatment philosophy targeting clinically meaningful 50%+ pain reduction.
Product overview
Metro Pain is a multidisciplinary interventional pain management clinic offering a comprehensive suite of services for chronic and complex pain. The practice operates a single unified clinical service model combining consultations, diagnostic procedures, and interventional treatments. Core offerings include image-guided injections (cortisone, facet joint, epidural, sacroiliac joint), radiofrequency neurotomy, neuromodulation devices (spinal cord and peripheral nerve stimulators), regenerative medicine (PRP therapy), ketamine infusions, and medication management. The clinic treats over 16 pain conditions spanning spinal, neuropathic, pelvic, and musculoskeletal pain. Services are delivered across Melbourne (Monash House Private Hospital, Clayton) and Brisbane (Bowen Hills Medical Specialist Centre) locations, led by Dr Paul Verrills and a team of pain specialists, anaesthetists, and allied health professionals.
Differentiator
Problem solved
Functional benefit
Products and services
- Pain Management Consultations
Quantifiable outcome
- 84,000+ patients treated since 1985
- +1 more outcomes
Companies that use Metro Pain
Customer profileSegments2 records
Ideal customer profiles2 records
Metro Pain technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Metro Pain partnerships and signals
Strategic signalScale indicators3 records
Recent moves2 records
Expansion highlights5 records
Metro Pain competitors and assessment
Company assessmentDirect peers
- Pain Matrix: Australian pain management clinic offering interventional procedures and chronic pain treatment across multiple locations. Directly comparable in specialty focus, procedure offerings, and GP-referral go-to-market.
- Hunter Pain Clinic: Newcastle-based interventional pain management practice offering similar procedural services to Metro Pain including spinal cord stimulation, nerve blocks, and radiofrequency procedures. Comparable specialist-physician service model.
- Pain Specialists Australia: Adelaide-based specialist pain medicine practice offering interventional pain management, neuromodulation, and multidisciplinary care. Comparable specialist-physician model with overlapping procedure offerings and similar GP-referral GTM.
- Northern Pain Centre: Sydney-based pain management clinic offering interventional pain procedures and multidisciplinary care. Comparable specialist practice model with similar procedural menu and referral-driven patient acquisition.
- Sydney Spine & Pain Centre: Multi-site Australian pain management clinic offering interventional procedures, neuromodulation, and multidisciplinary care. Direct competitor to Metro Pain in service model, with comparable physician-led approach and similar procedure menu.
Broad incumbents
- Healthia Limited: ASX-listed allied health network owning physiotherapy, podiatry, and pain management clinics across Australia. While much broader than Metro Pain, it competes in the same outpatient pain and musculoskeletal space and represents the roll-up/aggregator model that specialist clinics may eventually be acquired by.
Emerging players
- Sportsmed Biologic: Melbourne-based sports medicine and regenerative therapy practice offering PRP and biologic injections for musculoskeletal pain. Partial overlap with Metro Pain's regenerative medicine offering, focused on a narrower sports-medicine patient segment.
Regional players
- Olympic Park Sports Medicine Centre: Melbourne-based multidisciplinary sports medicine clinic offering pain management, physiotherapy, and rehabilitation. Comparable multidisciplinary model but with primary emphasis on sports medicine rather than chronic interventional pain.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Metro Pain social profiles
Digital presenceMetro Pain financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metro Pain leadership team
Management profileNumber of profiles
Profiles14 records
Metro Pain funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metro Pain M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metro Pain
What does Metro Pain do?
Metro Pain is a specialist interventional pain management clinic that diagnoses and treats chronic and complex pain conditions through personalised, evidence-based treatment plans. It combines specialist consultations, image-guided injection procedures (cortisone, nerve blocks, radiofrequency neurotomy), neuromodulation devices (spinal cord and peripheral nerve stimulators), regenerative medicine (PRP), ketamine infusions, and multidisciplinary rehabilitation. Services are delivered in-person at two Australian clinic locations (Melbourne and Brisbane) under a "Halving Pain" treatment philosophy targeting clinically meaningful 50%+ pain reduction.
Is Metro Pain a public or private company?
Metro Pain is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Metro Pain founded?
Metro Pain was founded in 1985. It employs 11 to 50 people.
Where is Metro Pain based?
Metro Pain is headquartered in Clayton, Australia, in the Oceania region.
How does Metro Pain make money?
Three revenue lines are on record. Consultation Services are the primary driver. The others are pain Procedure Services and government and Insurance Claims.
Who are Metro Pain's main competitors?
Direct peers on record are Pain Matrix, Hunter Pain Clinic, Pain Specialists Australia, Northern Pain Centre and Sydney Spine & Pain Centre. Healthia Limited is listed as a broad incumbent. Sportsmed Biologic is listed as an emerging player. Olympic Park Sports Medicine Centre is listed as a regional player.
Does Metro Pain have an API?
No public API is recorded for Metro Pain.
What industry is Metro Pain in?
Metro Pain's product category is Pain Management Healthcare Services. Its primary akta.pro industry code is HLAFABAH, Pain Management Clinics (Interventional & Medical), with a secondary code of HLAKAIAM, Pain Medicine (Interventional/Neuropathic Pain). Its NAICS code is 62134 and its SIC code is 8011.